Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
M. E. Britton
A. E. Denver
V. Mohamed-Ali
J. S. Yudkin
机构：
[1] University College London Medical School and Royal Free Hospital School of Medicine,Joint Department of Medicine, Whittington Hospital
来源：
Clinical Drug Investigation | 1998年 / 16卷
关键词：
Adis International Limited; Fast Plasma Glucose; Glibenclamide; Proinsulin; Sulphonylurea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: This study aimed to compare the effects of glimepiride and glibenclamide on glycaemic control and a range of risk factors for ischaemic heart disease (IHD), including concentrations of insulin-like molecules.
引用
收藏
页码：303 / 317
页数：14
相关论文
共 50 条
  • [21] Effects of long term monotherapy with Glimepiride vs Glibenclamide on the risk of macrovascular diseases in Japanese type 2 diabetic patients
    Isoyama, Ai
    Inukai, Kouichi
    Ikgami, Yuichi
    Ike-Bukuro, Kaori
    Awata, Takuya
    Katayama, Shigehir
    DIABETES, 2008, 57 : A616 - A616
  • [22] Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Hassan, Memy Hegazy
    Abd-Allah, Gamil Mohamed
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (05) : 1723 - 1730
  • [23] Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm?
    Poulsen, M. K.
    Henriksen, J. E.
    Vach, W.
    Dahl, J.
    Moller, J. E.
    Johansen, A.
    Gerke, O.
    Haghfelt, T.
    Hoilund-Carlsen, P. F.
    Beck-Nielsen, H.
    DIABETOLOGIA, 2010, 53 (04) : 659 - 667
  • [24] Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
    Can, Ayten
    Bekpinar, Seldag
    Gurdol, Figen
    Tutuncu, Yildiz
    Unlucerci, Yesim
    Dinccag, Nevin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E61 - E64
  • [25] Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm?
    M. K. Poulsen
    J. E. Henriksen
    W. Vach
    J. Dahl
    J. E. Møller
    A. Johansen
    O. Gerke
    T. Haghfelt
    P. F. Høilund-Carlsen
    H. Beck-Nielsen
    Diabetologia, 2010, 53 : 659 - 667
  • [26] Factors associated to glycaemic control in patients with type 2 diabetes
    Panarotto, Daniel
    Teles, Alisson Roberto
    Schumacher, Marina Verdi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 314 - 321
  • [27] Effects of pioglitzone and glimepiride on microvascular function in patients with diabetes mellitus type 2
    Forst, T
    Nguyen, M
    Langenfeld, M
    Friedrich, C
    Lübben, G
    Fennenkötter, U
    Kann, P
    Pfützner, A
    DIABETES, 2004, 53 : A308 - A308
  • [28] Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin
    Pettus, J.
    McNabb, B.
    Eckel, R. H.
    Skyler, J. S.
    Dhalla, A.
    Guan, S.
    Jochelson, P.
    Belardinelli, L.
    Henry, R. H.
    DIABETES OBESITY & METABOLISM, 2016, 18 (05): : 463 - 474
  • [29] Risk scores in ischaemic heart disease patients with type 2 diabetes, Isfahan, Iran
    Maracy, Mohammad Reza
    Hossein, Sayed Mohsen
    Amini, Massoud
    ACTA CARDIOLOGICA, 2008, 63 (06) : 729 - 734
  • [30] Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients
    Katakami, Naoto
    Kaneto, Hideaki
    Matsuhisa, Munehide
    Shimomura, Iichiro
    Yamasaki, Yoshimitsu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : E20 - E22
12345